Financial Statements — NHIV
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cash & Equivalents | 1.33 | -- |
| Total Current Assets | 1.60 | -- |
| Total Non-current Assets* | 202.72 | -- |
| Total Assets | 204.31 | 0.28 |
| Accounts Payable | 0.00 | 0.07 |
| Total Current Liabilities | 0.39 | 0.34 |
| Total Non-current Liabilities* | 7.04 | 0.00 |
| Total Liabilities* | 7.44 | 0.34 |
| Retained Earnings | (5.59) | (0.08) |
| Total Stockholder Equity | (5.59) | (0.06) |
* Derived from reported values
Income Statement
(in thousands USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Selling, General & Admin | 619.00 | 38.00 |
| Operating Income | (619.00) | -- |
| Pretax Income* | 854.00 | (38.00) |
| Tax Provision | 0.00 | 0.00 |
| Net Income | 854.00 | (38.00) |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 |
|---|
| Operating Cash Flow | (0.53) |
| Investing Cash Flow | (201.25) |
| Financing Cash Flow | 203.11 |
